Mobile phones cause lethal type of brain cancer, major study expected to declare

donderdag, 16 november 2017 - Categorie: Artikelen

13 nov. 2017

An important study into the safety of mobile (cell) phones is expected to report early next year that the
devices can trigger the most lethal form of brain cancer, glioblastoma multiforme (GBM).

The US National Toxicology Program (NTP) will shortly release the full results of its $25m research
project that involved exposing laboratory mice and rats to 10-minute bursts of cell-phone radiation
for two years.

In an early release of the initial findings, the NTP researchers discovered that brain tumours had
developed in the male rats, and that DNA in their brains had been damaged—something
that sceptics have said was not biologically possible.

Anticipating the full results, some academics are already calling for a reclassification of mobile
phone radiation as a definite carcinogen (cancer-causing agent) in humans. Dr Anthony B Miller, a
professor at the Dalla Lana School of Public Health at the University of Toronto, stated at a
lecture last month: ''The evidence indicating wireless is carcinogenic has increased and can
no longer be ignored.''

Dr Miller was part of the working group created by the World Health Organization that,
in 2011, classified mobile phone radiation as a group 2B carcinogen, which means it is possibly
harmful to humans.

But he says that, based on new evidence from the NTP and others, the classification should
be stronger, and reflect the true harm that the radiation can cause.

The early findings of the NTP study, which was initiated by the US's Food and Drug Administration
(FDA), had a mixed reception. The American Cancer Society altered its advice about mobile phone
use and urged people to limit the time the phones are held to the head, but others—including
groups funded by the mobile phone industry—were sceptical. They pointed out that brain cancer rates
haven't increased in the years mobile phones have been used, but that is true only for brain tumours
in general, while rates of GBMs have risen.

Lees verder in de categorie Artikelen | Terug naar homepage | Lees de introductie